Cargando…
BRCA mutated pancreatic cancer: A change is coming
Pancreatic cancer remains a leading cause of cancer-related death with few available therapies for advanced disease. Recently, patients with germline BRCA mutations have received increased attention due to advances in the management of BRCA mutated ovarian and breast tumors. Germline BRCA mutations...
Autores principales: | Rosen, Michael N, Goodwin, Rachel A, Vickers, Michael M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108028/ https://www.ncbi.nlm.nih.gov/pubmed/34007132 http://dx.doi.org/10.3748/wjg.v27.i17.1943 |
Ejemplares similares
-
Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007) -
BRCA mutations and gastrointestinal cancers: When to expect the unexpected?
por: Maccaroni, Elena, et al.
Publicado: (2021) -
UK BRCA mutation testing in patients with ovarian cancer
por: George, Angela
Publicado: (2015) -
Protein profiling comes of age
por: Tomlinson, Ian M, et al.
Publicado: (2001) -
BRCA1/2 Mutation Status Impact on Autophagy and Immune Response: Unheralded Target
por: Morand, Susan, et al.
Publicado: (2020)